Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (201-210 of 340) with videos related to

Pageof 34
Sort By:
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
NPJ Precision Oncology|July 24, 2025
Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selectionDaisuke Nishizaki, Razelle Kurzrock, Jacob J Adashek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcomeYoshitsugu Mitani, Pulivarthi H Rao, P Andrew Futreal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinomaYang Deng, Huakang Tu, Jeanne A Pierzynski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinomaAbenaa M Brewster, J Jack Lee, Gary L Clayman, et al.
Nature Communications|October 5, 2016
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitizeStephen R Adams, Howard C Yang, Elamprakash N Savariar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2010
Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesisImad Shureiqi, Dongning Chen, R Sue Day, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic MetabolismXingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka, et al.
Cancer|July 19, 2002
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Pageof 34

Showing results (201-210 of 340) with videos related to

Sort By:
Pageof 34
The Prostate|April 21, 2015
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention TrialChristopher M Heaphy, Gaurav Gaonkar, Sarah B Peskoe, et al.
NPJ Precision Oncology|July 24, 2025
Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selectionDaisuke Nishizaki, Razelle Kurzrock, Jacob J Adashek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcomeYoshitsugu Mitani, Pulivarthi H Rao, P Andrew Futreal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2018
Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinomaYang Deng, Huakang Tu, Jeanne A Pierzynski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinomaAbenaa M Brewster, J Jack Lee, Gary L Clayman, et al.
Nature Communications|October 5, 2016
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitizeStephen R Adams, Howard C Yang, Elamprakash N Savariar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2010
Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesisImad Shureiqi, Dongning Chen, R Sue Day, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasiaJames R Marshall, Wael Sakr, David Wood, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic MetabolismXingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka, et al.
Cancer|July 19, 2002
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Pageof 34